The Maharashtra Food and Drug Administration (FDA) has initiated legal scrutiny involving high-profile actors Shah Rukh Khan and Ajay Devgn. The notices pertain to the actors' participation in promotional campaigns for Vimal, a brand associated with tobacco products. The move follows ongoing public and regulatory debate regarding the endorsement of surrogate tobacco products by celebrities.

Tukaram Mundhe, the Commissioner of the Maharashtra FDA, confirmed the issuance of these notices. In his public comments, Mundhe adopted a firm stance, declaring that "nobody will be spared" in the enforcement of health and advertising regulations. The FDA's action is part of a broader effort to curb the promotion of substances that pose significant public health risks. While the specific legal consequences for the actors remain to be detailed, the notices signal an escalation in the state's regulatory oversight of celebrity endorsements for potentially harmful products.

Currently, the actors have not issued a formal public response to the specific notices mentioned by the FDA. The situation highlights a tension between commercial advertising practices and state-level public health mandates in India. Regulatory bodies have increasingly scrutinized how brands use surrogate advertising—promoting non-tobacco products under the same brand name as tobacco items—to bypass strict bans on direct tobacco advertising. The FDA’s intervention suggests a shift toward holding individual endorsers accountable for their role in these marketing campaigns.